This statistic shows the intravenous immunoglobulin (IVIG) global market share in 2015, by leading companies. Grifols held the largest market share with some 25 percent while CSL and Baxalta held 20 percent each.
Intravenous immunoglobulin (IVIG) global market share in 2015, by company
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Grifols. (June 7, 2017). Intravenous immunoglobulin (IVIG) global market share in 2015, by company [Graph]. In Statista. Retrieved October 03, 2024, from https://www.statista.com/statistics/758041/global-market-share-ivig-by-leading-companies/
Grifols. "Intravenous immunoglobulin (IVIG) global market share in 2015, by company." Chart. June 7, 2017. Statista. Accessed October 03, 2024. https://www.statista.com/statistics/758041/global-market-share-ivig-by-leading-companies/
Grifols. (2017). Intravenous immunoglobulin (IVIG) global market share in 2015, by company. Statista. Statista Inc.. Accessed: October 03, 2024. https://www.statista.com/statistics/758041/global-market-share-ivig-by-leading-companies/
Grifols. "Intravenous Immunoglobulin (Ivig) Global Market Share in 2015, by Company." Statista, Statista Inc., 7 Jun 2017, https://www.statista.com/statistics/758041/global-market-share-ivig-by-leading-companies/
Grifols, Intravenous immunoglobulin (IVIG) global market share in 2015, by company Statista, https://www.statista.com/statistics/758041/global-market-share-ivig-by-leading-companies/ (last visited October 03, 2024)
Intravenous immunoglobulin (IVIG) global market share in 2015, by company [Graph], Grifols, June 7, 2017. [Online]. Available: https://www.statista.com/statistics/758041/global-market-share-ivig-by-leading-companies/